During the past decade, Clinical and Translational Research Center, Hospital of University of Pennsylvania conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 11 clinical trials were completed, i.e. on average, 275% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical and Translational Research Center, Hospital of University of Pennsylvania" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 4 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Pennsylvania Department of Health" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Clinical and Translational Research Center, Hospital of University of Pennsylvania" are "Healthy" (3 trials), "Hypoglycemia Unawareness" (2 trials), "Frailty" (1 trials), "Frailty Syndrome" (1 trials) and "Hyperlipidemia" (1 trials). Many other conditions were trialed in "Clinical and Translational Research Center, Hospital of University of Pennsylvania" in a lesser frequency.

Most popular intervention types in "Clinical and Translational Research Center, Hospital of University of Pennsylvania" are "Drug" (10 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Atorvastatin" (1 trials), "Blood draw" (1 trials), "Bococizumab (PF-04950615;RN316)" (1 trials) and "Celecoxib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical and Translational Research Center, Hospital of University of Pennsylvania" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical and Translational Research Center, Hospital of University of Pennsylvania". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Clinical and Translational Research Center, Hospital of University of Pennsylvania, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical and Translational Research Center, Hospital of University of Pennsylvania, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".